In the latest Market Talks covering the Health Care sector, Nomura analysts have stated their preference for Indonesia’s quality companies due to various external risks such as rising political tensions and uncertainties about China’s economic recovery. These companies have higher returns on assets than their peers, a rising ROA trend, and ROA stability throughout cycles.
Nomura’s top picks in this sector are all buy-rated and include Bank Central Asia, Sumber Alfaria Trijaya, Indofood CBP Sukses Makmur, Medikaloka Hermina, Indosat, Harum Energy, and AKR Corporindo. The analysts’ report highlights the quality and stability of these companies, making them preferred choices in the current market environment.
The focus on Indonesian companies by Nomura reflects their confidence in the country’s economy and its ability to withstand external risks and uncertainties. This information provides valuable insights for investors looking to make informed decisions in the market.
These companies’ strong performance and favorable ratings from Nomura make them an important focus within the health care sector. Their stability and potential for growth make them promising choices for investors seeking opportunities in the market. The exclusive coverage of these Market Talks on Dow Jones Newswires further underscores the significance of this information for industry professionals and investors alike.